India Glycols FY26 Results: PAT up 27%, EBITDA +25%

Why India Glycols’ FY26 numbers matter

India Glycols Ltd (BOM:500201) reported a stronger FY26, led by higher profitability, better margins, and a visible improvement in its balance sheet. The company’s FY26 net revenue rose 11.8% to ₹4,211 crore, while EBITDA increased 24.5% to ₹654 crore. Profit after tax (PAT) for FY26 was reported at about ₹293 crore, a 26.8% year-on-year rise, with PAT margin expanding to 6.9%. The company also flagged margin improvement across key segments such as portable spirits, allied products, and chemicals.

A key part of the FY26 story was deleveraging. The company reduced its debt-to-equity ratio from 0.9 to 0.6 and improved its interest coverage ratio to 4.13. In the March 2026 quarter, finance costs also declined sharply, reflecting the combined impact of debt reduction, a preferential allotment, and internal accruals.

FY26 financial snapshot: revenue, EBITDA and PAT

Management commentary indicated FY26 gross revenues of ₹9,827 crore, up 8.7%. Net revenues were ₹4,211 crore, up 11.8%, with growth led largely by portable spirits and biofuels. EBITDA came in at ₹654 crore, up 24.5% year-on-year. EBITDA margin improved to 15.5%, up 162 basis points.

On profitability, FY26 PAT was described at around ₹293-₹296 crore in different disclosures, and was also reported as ₹292.76 crore for FY26 consolidated net profit. PAT growth was 26.8% year-on-year, and PAT margin expanded to 6.9%, up 84 basis points.

Standalone performance was also highlighted. India Glycols reported a 56.5% year-on-year increase in standalone net profit to ₹282.33 crore for FY26, with revenue rising to ₹9,826.20 crore.

Q4 FY26 performance: sharper gains from costs and interest savings

For the quarter ended March 31, 2026, consolidated net profit rose to ₹86.88 crore from ₹64.02 crore in the same period of the previous year. Consolidated revenue from operations stood at ₹2,360.01 crore versus ₹2,188.65 crore year-on-year, and another reported figure cited revenue of ₹2,360.63 crore (up 7.78%).

Q4 consolidated EBITDA improved to ₹167.12 crore from ₹147.53 crore year-on-year. The Q4 consolidated EBITDA margin expanded to 9.89% from 6.76%, indicating better operating leverage.

Separately, management commentary presented the quarter on a “net revenue” base. On that basis, Q4FY26 net revenue was ₹976 crore (up 13.1%), EBITDA was ₹167 crore (up 13.3%), and the EBITDA margin was 17.1% (up 5 basis points). These two margin sets reflect different revenue bases used in disclosures.

What drove FY26 margin expansion

The company attributed the margin improvement to performance across portable spirits, allied products, and chemicals, with chemicals and allied products specifically cited as leading contributors. The FY26 EBITDA margin improved by 162 basis points to 15.5%, and PAT margin expanded to 6.9%.

In Q4FY26, the company also pointed to the combined benefit of operating profit improvements and interest savings. Finance cost declined to ₹26 crore in Q4FY26 from ₹45 crore in Q4FY25, supporting net profit growth.

Biofuels: strong growth with defined margins

The biofuels segment had what the company described as an excellent year, with growth of 40.9%. It delivered a top-line of ₹1,470 crore and an EBIT margin of 7.8%. The segment’s performance was also cited as a key driver of overall revenue growth in FY26.

For investors, the biofuels numbers are notable because they include both growth and a disclosed profitability metric (EBIT margin), giving clearer visibility into segment economics compared with topline-only updates.

Portable spirits: leadership, premiumization, and a weak quarter

India Glycols said it maintained market leadership in the portable spirits segment, with a continued focus on premiumization and new brand launches. At the same time, the company acknowledged EBIT margin pressure in the portable spirits segment in the last quarter, attributing it to an “odd quarter” performance.

This combination suggests the segment remains strategically important for growth and brand building, while quarter-to-quarter profitability can be volatile. The company’s own commentary frames the pressure as period-specific rather than structural, but the disclosure also signals that investors should track segment margins closely.

Debt reduction shows up in coverage metrics

A clearer improvement in financial risk indicators was a highlight of the FY26 update. India Glycols reduced its debt-to-equity ratio from 0.9 to 0.6, and improved its interest coverage ratio to 4.13. In the March 2026 quarter, the company also reported its highest quarterly operating profit to interest ratio at 6.30 times.

These metrics tie in with the decline in quarterly finance costs to ₹26 crore from ₹45 crore, which the company linked to debt reduction supported by a preferential allotment and internal accruals.

Key numbers at a glance

Market impact: what investors are likely to track next

The FY26 result set combines higher operating profitability with a tangible drop in financing costs, which is visible in both the improved interest coverage ratio and Q4 finance cost reduction. From a market lens, the most measurable positives are the 24.5% rise in EBITDA to ₹654 crore, the margin improvement to 15.5%, and the year-on-year PAT growth of 26.8% to about ₹293 crore.

At the segment level, biofuels delivered strong growth with disclosed EBIT margins, while portable spirits remained a growth driver but saw quarter-end margin pressure. For near-term tracking, investors typically watch whether the “odd quarter” margin pressure in portable spirits normalises, and whether the lower leverage position sustains further reductions in finance costs.

Conclusion

India Glycols’ FY26 update points to improved profitability, expanding margins, and better balance sheet metrics, alongside strong biofuels growth and continued focus on premiumization in portable spirits. The company announced the FY26 results on May 14, 2026, following a board meeting, and the next key datapoints will be subsequent quarterly margins, segment profitability trends, and the trajectory of debt and finance costs.